Related Experiment Video
Updated: Jul 27, 2025
06:03
Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
Published on: February 6, 2020
6.7K
Physician Perceptions on Cancer Screening for LGBTQ+ Patients
Nicolas G Nelson1, Joseph F Lombardo1, Ayako Shimada2
1Department of Radiation Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Cancers
|June 10, 2023
Summary
Healthcare providers acknowledge unique health needs of the LGBTQ+ community but lack sufficient training for cancer screenings. Improved education and clearer guidelines are needed for equitable cancer care for lesbian, gay, bisexual, transgender, queer, and other sexual and gender minority patients.
Area of Science:
- Health Disparities
- Oncology
- Medical Education
Background:
- LGBTQ+ individuals face cancer disparities due to risk factors and barriers.
- Health literacy gaps and systemic issues contribute to lower screening rates.
- Understanding healthcare providers' perspectives on LGBTQ+ cancer screening is crucial.
Purpose of the Study:
- To assess healthcare providers' experiences, knowledge, and perceptions regarding cancer screening for LGBTQ+ patients.
- To identify barriers and needs for improving LGBTQ+ cancer care.
- To inform the development of targeted educational interventions.
Main Methods:
- A 20-item survey was distributed to 355 physicians via professional organizations.
- The survey evaluated provider training, understanding of LGBTQ+ health, and perceptions of patient concerns.
- Data were analyzed using descriptive statistics and significance testing (p-values).
Main Results:
- Only 28% of providers reported prior LGBTQ+-related training.
- Most providers (85%) recognized unique LGBTQ+ health needs, but only 46% felt confident understanding them.
- Prior training positively correlated with recognizing the importance of sexual orientation and confidence in LGBTQ+ health.
Conclusions:
- Most providers acknowledge LGBTQ+ patients' unique health needs, despite limited formal training.
- A lack of consensus exists on cancer screening for specific LGBTQ+ subpopulations.
- There is a clear need for enhanced provider education and standardized screening guidelines for LGBTQ+ individuals.
Keywords:
LGBTQ+cancer disparitiescancer screeninggendersexual and gender minoritiesstructural and social determinantsMore Related Videos
06:11Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
9.9K
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
307
Related Concept Videos
01:27Nursing Ethical Principles II
1.0K
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
1.0K
02:59Cancer Prevention
6.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.2K
01:30Cancer Vaccines
434
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
434
02:49Cancer Therapies
7.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.8K
02:18Cancer
48.8K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.8K
01:21Cancer Survival Analysis
402
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
402